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Importance 
Epizootic lymphangitis is a debilitating fungal disease seen mainly in equids. 
The most common form of this disease is an ulcerative, suppurative, spreading 
dermatitis and lymphangitis; however, other forms including pneumonia or 
ulcerative conjunctivitis also occur. Epizootic lymphangitis spreads most  readily 
where large numbers of animals are assembled, and it was a serious problem during 
the early twentieth century when large numbers of horses were stabled together. 
This disease continues to be a significant concern in some countries such as 
Ethiopia, where the prevalence in carthorses is nearly 19%, and economic losses 
from this disease are high. 
Etiology 
Epizootic lymphangitis results from infection by a dimorphic fungus, 
Histoplasma capsulatum var. farciminosum. This organism has also been known as 
Histoplasma farciminosum, Cryptococcus farciminosis, Zymonema farciminosa and 
Saccharomyces farciminosus. H. capsulatum var. farciminosum exists as a yeast in 
animal tissues and a saprophytic mycelium in the environment.  
Recent genetic evidence suggests that the isolates causing epizootic lymphangitis 
originated independently from different geographical clades of Histoplasma 
capsulatum. Based on this evidence, some authors question the existence of the 
variety H. capsulatum var. farciminosum, and consider epizootic lymphangitis to be a 
form of histoplasmosis, caused by H. capsulatum, that occurs in horses. 
Species Affected 
Epizootic lymphangitis mainly affects horses, donkeys and mules. H. capsulatum 
var. farciminosum has also been reported in camels, cattle and dogs, and experimental 
infections have been established in mice, guinea pigs and rabbits. 
Geographic Distribution 
Epizootic lymphangitis is more common in tropical and subtropical regions than 
in temperate zones. Currently, H. capsulatum var farciminosum is endemic in some 
countries in the Mediterranean region, and in parts of Africa and Asia including India, 
Pakistan and Japan. Sporadic cases have been reported from other parts of the world. 
Transmission 
H. capsulatum var. farciminosum infects animals through wounds. Both the yeast 
form found in animals and the mycelial form in the environment can produce 
epizootic lymphangitis after experimental inoculation. The source of the organisms 
can be the skin lesions and nasal and ocular exudates of infected animals, or the soil. 
In its saprophytic mycelial phase, H. capsulatum var. farciminosum can survive for 
many months in warm, moist environments. This organism can also be spread on 
fomites such as grooming or harness equipment.  
Biting flies in the genera Musca and Stomoxys are thought to spread the 
conjunctival form. Flies may also transmit the skin form mechanically when they feed 
on lesions and exudates. Ticks might be involved in transmission; in a recent study, 
tick bites appeared to be a predisposing factor for epizootic lymphangitis in mules. 
The pulmonary form, which is rare, probably develops when an animal inhales the 
organism.  
Incubation Period 
The incubation period is usually several weeks to 2 months. In a recent study, the 
incubation period was much longer in a horse inoculated with mycelial organisms 
than in a horse inoculated with the yeast form.  
Clinical Signs 
The most common form of epizootic lymphangitis affects the skin and 
lymphatics. It often occurs on the extremities, chest wall, face and neck, but can be 
seen wherever the organism is inoculated into a wound. The first symptom is a  
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painless, freely moveable intradermal nodule, 
approximately 2 cm in diameter. This nodule enlarges and 
eventually bursts. In some cases, the lesions may be small 
and inconspicuous, and heal spontaneously. More often, the 
skin ulcers grow, with cycles of granulation and partial 
healing followed by new eruptions. The surrounding skin is 
edematous at first, and later becomes thickened, hard and 
variably painful. The skin over the nodules may be fixed to 
the underlying tissues. The regional lymph nodes can be 
enlarged, but fever is uncommon. The infection also 
spreads along the lymphatics, causing cord–like thickening 
and further skin involvement. These cycles of exacerbation 
and partial healing gradually resolve, leaving only a scar. 
The process usually takes about 2 to 3 months. Epizootic 
lymphangitis sometimes spreads to the underlying joints 
and results in severe arthritis. Occasionally, there may be 
ulcerative conjunctivitis, keratoconjunctivitis, a serous or 
purulent nasal discharge, or pneumonia. Extensive lesions 
can end in death; this usually occurs in areas where animals 
are in poor condition and veterinary care is limited.  
In dogs, both cutaneous infections and infections that 
disseminate to internal organs have been reported. 
Post Mortem Lesions      Click to view images 
At necropsy, areas of the skin and subcutaneous tissue 
are thickened, and the skin may be fused to the underlying 
tissues. The regional lymph nodes may be enlarged and 
inflamed. Nodules in the skin have a thick, fibrous capsule 
and the affected lymphatic vessels are usually thickened 
or distended. Both nodules and lymphatics contain 
purulent exudates. In some cases, the lesions may extend 
to the underlying joints, resulting in arthritis, periarthritis 
or periostitis. Multiple, small, gray–white nodules or 
ulcers with raised borders and granulating bases may be 
apparent on the nasal mucosa, and lesions may be found 
on the conjunctiva and cornea. The lungs, spleen, liver, 
testes and other internal organs may also contain nodules 
and abscesses. 
Morbidity and Mortality 
Epizootic lymphangitis is more common in the tropics 
and subtropics than in temperate areas. Warm, moist 
conditions allow the organism to survive in the soil for 
months. The incidence of this disease  is much higher 
when large numbers of animals are gathered together than 
when populations are less dense. The prevalence can be 
high in some areas. In Ethiopia, nearly 19% of the 
carthorses in warm, humid areas are affected, and the 
overall prevalence was 21% among mules in two towns. 
Death is uncommon if an animal is in good condition and 
receives good care, but animals with extensive lesions 
may die. 
 
 
 
Diagnosis 
Clinical 
The symptoms are highly suggestive in cases with skin 
lesions. Epizootic lymphangitis should be suspected in 
horses, mules or donkeys with skin nodules or ulcers that 
follow a pattern of partial healing followed by renewed 
eruption. This disease must be differentiated by laboratory 
tests from other conditions such as glanders. 
Differential diagnosis 
The differential diagnosis includes the skin form of 
glanders (farcy), strangles, ulcerative lymphangitis, 
sporotrichosis, cryptococcosis, sarcoids and cutaneous 
lymphosarcoma. Epizootic lymphangitis also resembles 
histoplasmosis, which is caused by Histoplasma 
capsulatum var. capsulatum. 
Laboratory tests 
Epizootic lymphangitis can be diagnosed by detecting 
H. capsulatum var. farciminosum in lesions. Histopathology 
or the direct examination of smears from exudates is helpful 
in diagnosis. In established lesions, the organisms may be 
numerous. Tissue sections can be stained with hematoxylin 
and eosin, periodic acid–Schiff or Gomori methenamine–
silver staining. In a Gram–stained preparation, H. 
capsulatum is a Gram–positive, pleomorphic, ovoid to 
globose structure that is approximately 2–5 µm in diameter. 
Organisms are found extracellularly or in macrophages, and 
can be seen singly or in groups. Each yeast is often 
surrounded by a capsule, which does not stain and appears 
as a halo. An immunofluorescent technique to demonstrate 
H. capsulatum has also been developed. Electron 
microscopy may be used on skin biopsy samples. 
H. capsulatum var farciminosum can be cultured on a 
variety of fungal media including mycobiotic agar, enriched 
Sabouraud’s dextrose agar with 2.5% glycerol, brain–heart 
infusion agar with 10% horse blood, and pleuropneumonia-
like organism (PPLO) nutrient agar with 2% dextrose and 
2.5% glycerol (pH 7.8). This organism grows as a 
mycelium at cooler temperatures. These colonies grow 
slowly and develop in approximately 2 to 8 weeks at 26°C. 
They are dry, granular, wrinkled and grayish-white, 
becoming brown as they age. Aerial forms are rare. On 
microscopic examination, the hyphae are hyaline, septate, 
branched, pleomorphic and Gram stain variable. A variety 
of conidia including chlamydospores, arthroconidia and 
blastoconidia may be found, but H. capsulatum var 
farciminosum does not produce the large, round, double-
walled macroconidia often seen in H. capsulatum var. 
capsulatum cultures. Isolation may fail in up to half of the 
cases.  
Conversion to the yeast form can be demonstrated at 
35-37°C by subculturing the mycelium into brain–heart 
infusion agar containing 5% horse blood, or by growing the 
organism in Pine’s medium in 5% CO2. The yeast phase 
forms colonies that are flat, raised, wrinkled, white to 
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grayish brown, and pasty. Complete conversion occurs only 
after repeated serial transfers to fresh media. Animal 
inoculation into immunosuppressed mice or other 
laboratory animals has also been used for diagnosis. 
Antibodies can usually be found in animals with 
clinical signs. Serological tests include fluorescent antibody 
tests, enzyme–linked immunosorbent assays (ELISA) and 
passive hemagglutination. Skin hypersensitivity tests can be 
used to detect cell-mediated immune responses.  
Samples to collect 
Before collecting or sending any samples from 
animals with a suspected foreign animal disease, the 
proper authorities should be contacted. Samples should 
only be sent under secure conditions and to authorized 
laboratories to prevent the spread of the disease. Rare 
human infections with H. capsulatum var farciminosum 
have been reported, and  precautions should be taken to 
prevent zoonotic disease. 
Samples should be collected from unruptured nodules 
for culture. These samples should be placed in a liquid 
nutrient medium that contains antibacterials. They should 
be kept refrigerated and sent to the laboratory on wet ice as 
soon as possible. Air–dried smears from exudates should be 
prepared on glass slides and fixed immediately for direct 
examination. Samples of lesions that include both viable 
and nonviable tissue should be collected in 10% neutral 
buffered formalin for histopathology. Serum samples 
should also be submitted for serology.  
Recommended actions if 
epizootic lymphangitis is suspected 
Notification of authorities 
Epizootic lymphangitis must be reported to state or 
federal authorities immediately upon diagnosis or suspicion 
of the disease.  
Federal: Area Veterinarians in Charge (AVIC): 
http://www.aphis.usda.gov/animal_health/area_offices/ 
State Veterinarians:   
http://www.usaha.org/Portals/6/StateAnimalHealthOfficial
s.pdf 
Control 
Epizootic lymphangitis can be controlled or 
eradicated by quarantines and the euthanasia of infected 
animals. Screening may help identify cases. Infected 
premises and equipment must be thoroughly cleaned and 
disinfected. H. capsulatum can be inactivated by 1% 
sodium hypochlorite, glutaraldehyde, formaldehyde and 
phenolic disinfectants. Its susceptibility to 70% ethanol is 
questionable. This organism is also destroyed by moist 
heat of 121ºC for at least 15 minutes. Bedding should be 
burned. Organisms in the soil may survive for long 
periods. 
In endemic areas, good cleaning and disinfection can 
help prevent H. capsulatum var farciminosum from 
spreading between animals. Care should be taken to prevent 
transmission on grooming equipment or harnesses. Early 
cases may be treated with sodium or potassium iodide, but 
the lesions may later recur. Amphotericin B has also been 
used, but it is more expensive. In some cases, nodules may 
be drained and packed with iodine, or excised surgically. 
Vaccines are not widely available; however, live and 
inactivated vaccines have been used in some endemic 
regions. Published reports suggest that some of these 
vaccines may be promising.  
Public Health 
Rare human infections by Histoplasma capsulatum var. 
farciminosum have been reported.  
Internet Resources 
The Merck Veterinary Manual 
http://www.merckvetmanual.com/mvm/index.jsp  
United States Animal Health Association. Foreign Animal 
Diseases  
http://www.aphis.usda.gov/emergency_response/downlo
ads/nahems/fad.pdf 
World Organization for Animal Health (OIE) 
http://www.oie.int  
OIE Manual of Diagnostic Tests and Vaccines for  
Terrestrial Animals  
http://www.oie.int/international-standard-
setting/terrestrial-manual/access-online/ 
OIE Terrestrial Animal Health Code 
http://www.oie.int/international-standard-
setting/terrestrial-code/access-online/ 
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